Evidence map›Paper›PMID 10637197›Full record

Trial reportCirculation2000

Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.

C M Gibson, C P Cannon, S A Murphy, K A Ryan, R Mesley, S J Marble, C H McCabe, F Van De Werf, E Braunwald

8 registry-linked trialsAbstract readClinical TrialControlled Clinical Trial
PubMed Publisher
In one paragraph

Trial report in Circulation, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 8 registered trials, which are not on this map. Cited by 191 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
191citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02201667 phase4unknown statusnot on this mapstarted 2014, after this paper: background citation

An Open-label Study Evaluating the Acute Efficacy of Treatment With Ticagrelor Versus Clopidogrel on Myocardial Tissue-level Perfusion Assessed by TMPFC and MRI in Patients With High-risk NSTE-ACS Undergoing Early PCI(EARLY-MYO II)

TypeinterventionalSponsorRenJi HospitalRan2014 to 2016Enrolled444ConditionsAcute Coronary SyndromeArmsTicagrelor, clopidogrel, Aspirin, PCI
NCT03252665 phase4unknown statusnot on this mapstarted 2017, after this paper: background citation

Efficacy of Intracoronary Infusion of Different Medicine With Targeted Perfusion Catheter on Myocardial Perfusion in Patients With STEMI Undergoing Primary PCI:an Open,Prospective,Randomized,Multicenter Trial.

TypeinterventionalSponsorRenJi HospitalRan2017 to 2019Enrolled600ConditionsST Segment Elevation Myocardial InfarctionArmsAlprostadil, Nicorandil, Nitroglycerin
NCT03296670 phase4completednot on this mapstarted 2015, after this paper: background citation

Intracoronary Infusion of Alprostadil and Nitroglycerin With Targeted Perfusion Microcatheter in STEMI Patients With Coronary Slow Flow Phenomenon

TypeinterventionalSponsorRenJi HospitalRan2015 to 2017Enrolled57ConditionsST Segment Elevation Myocardial Infarction, Coronary Slow Flow PhenomenonArmsAlprostadil, Nitroglycerin
NCT03753269 phase4unknown statusnot on this mapstarted 2019, after this paper: background citation

Efficacy of Early Intracoronary Administration of Fasudil Hydrochloride on Myocardial Perfusion in the Primary PCI of ST-elevation Myocardial Infarction: an Prospective, Randomized and Multicenter Trial

TypeinterventionalSponsorRenJi HospitalRan2019 to 2022Enrolled600ConditionsST Segment Elevation Myocardial InfarctionArmsFasudil Hydrochloride, Placebo saline
NCT04033861 phase4unknown statusnot on this mapstarted 2019, after this paper: background citation

Prospective Observational Clinical Study:The Impact of Early rhBNP on Myocardial Remodeling and Reperfusion in Patients With ST-segment Elevation Myocardial Infarction After Percutaneous Coronary Intervention

TypeinterventionalSponsorRenJi HospitalRan2019 to 2023Enrolled352ConditionsST Segment Elevated Myocardial InfarctionArmsrhBNP, Control
NCT04651842 completednot on this mapstarted 2018, after this paper: background citation

Impact of Acute Insulin Resistance on Myocardial Blush in Non- Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention

TypeobservationalSponsorAssiut UniversityRan2018 to 2019Enrolled240ConditionsInsulin Resistance and PCIArmsPCI
NCT06327659 phase3unknown statusnot on this mapstarted 2024, after this paper: background citation

Efficacy of Using 50 ml Syringe Manual Thrombectomy Catheter in Patients With Heavy Thrombus Burden Undergoing Primary Percutaneous Coronary Intervention

TypeinterventionalSponsorHelwan UniversityRan2024 to 2025Enrolled88ConditionsSTEMI - ST Elevation Myocardial Infarction, Thrombosis CardiacArms30 mL syringe manual thrombectomy catheter, 50 mL syringe manual thrombectomy catheter
NCT06947564 completednot on this mapstarted 2012, after this paper: background citation

Angiography-derived Index of Microcirculatory Resistance Predicts Microvascular Obstruction and Infarct Size in Patients With ST-segment-elevation Myocardial Infarction

TypeobservationalSponsorRenJi HospitalRan2012 to 2024Enrolled843ConditionsCoronary Artery Disease, STEMI - ST Elevation Myocardial Infarction, Microvascular Coronary Artery DiseaseArmsCMR
3 · Its place in the literature

Who cites it

191 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2021
    Trial
  13. Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2021
    Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

131 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

C M GibsonCardiovascular Divisions of the Departments of Medicine, the University of California at San Francisco, San Francisco 94118, USA.
C P Cannon
S A Murphy
K A Ryan
R Mesley
S J Marble
C H McCabe
F Van De Werf
E Braunwald

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough improved epicardial blood flow (as assessed with either TIMI flow grades or TIMI frame count) has been related to reduced mortality after administration of thrombolytic drugs, the relationship of myocardial perfusion (as assessed on the coronary arteriogram) to mortality has not been examined. METHODS AND

resultsA new, simple angiographic method, the TIMI myocardial perfusion (TMP) grade, was used to assess the filling and clearance of contrast in the myocardium in 762 patients in the TIMI (Thrombolysis In Myocardial Infarction) 10B trial, and its relationship to mortality was examined. TMP grade 0 was defined as no apparent tissue-level perfusion (no ground-glass appearance of blush or opacification of the myocardium) in the distribution of the culprit artery; TMP grade 1 indicates presence of myocardial blush but no clearance from the microvasculature (blush or a stain was present on the next injection); TMP grade 2 blush clears slowly (blush is strongly persistent and diminishes minimally or not at all during 3 cardiac cycles of the washout phase); and TMP grade 3 indicates that blush begins to clear during washout (blush is minimally persistent after 3 cardiac cycles of washout). There was a mortality gradient across the TMP grades, with mortality lowest in those patients with TMP grade 3 (2.0%), intermediate in TMP grade 2 (4.4%), and highest in TMP grades 0 and 1 (6.0%; 3-way P=0.05). Even among patients with TIMI grade 3 flow in the epicardial artery, the TMP grades allowed further risk stratification of 30-day mortality: 0.73% for TMP grade 3; 2.9% for TMP grade 2; 5.0% for TMP grade 0 or 1 (P=0.03 for TMP grade 3 versus grades 0, 1, and 2; 3-way P=0.066). TMP grade 3 flow was a multivariate correlate of 30-day mortality (OR 0.35, 95% CI 0.12 to 1.02, P=0.054) in a multivariate model that adjusted for the presence of TIMI 3 flow (P=NS), the corrected TIMI frame count (OR 1.02, P=0.06), the presence of an anterior myocardial infarction (OR 2.3, P=0.03), pulse rate on admission (P=NS), female sex (P=NS), and age (OR 1.1, P<0.001).

conclusionsImpaired perfusion of the myocardium on coronary arteriography by use of the TMP grade is related to a higher risk of mortality after administration of thrombolytic drugs that is independent of flow in the epicardial artery. Patients with both normal epicardial flow (TIMI grade 3 flow) and normal tissue level perfusion (TMP grade 3) have an extremely low risk of mortality.

Indexed as

AgedAntifibrinolytic AgentsCoronary AngiographyCoronary CirculationFemaleHumansMaleMiddle AgedMyocardial InfarctionPericardiumRandomized Controlled Trials as TopicRisk AssessmentAntifibrinolytic Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 2 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.